Low-dose 4-factor PCC for urgent warfarin reversal

被引：0
|
作者：
Zemrak, W. [1 ]
Smith, K. [1 ]
Rolfe, S. [1 ]
Hayes, T. [2 ]
Trowbridge, R. [3 ]
Seder, D. [4 ]
机构：
[1] Maine Med Ctr, Pharm Serv, Portland, ME USA
[2] Maine Med Ctr, Pathol, Portland, ME USA
[3] Maine Med Ctr, Hosp Med, Portland, ME USA
[4] Maine Med Ctr, Crit Care Serv, Portland, ME USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO367-WED
引用
收藏
页码：885 / 885
页数：1
相关论文
共 50 条
  • [21] Low Dose PCC for Reversal of Warfarin Induced Intracerebral Hemorrhage
    Boctor, F. N.
    Sheahan, B.
    Nikolis, N. M.
    Heaton, W.
    Hussain, E.
    TRANSFUSION, 2012, 52 : 52A - 52A
  • [22] EVALUATION OF 4-FACTOR PCC FOR HEMOSTASIS AND COAGULOPATHY REVERSAL IN NONANTICOAGULATED PATIENTS
    Jones, Savannah
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 309 - 309
  • [23] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Mary Hormese
    Alex Littler
    Brian Doane
    Nicole Glowacki
    Ann Khimani
    Nicole Vivacqua
    Karina Rudenberg
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 828 - 835
  • [24] Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
    Hormese, Mary
    Littler, Alex
    Doane, Brian
    Glowacki, Nicole
    Khimani, Ann
    Vivacqua, Nicole
    Rudenberg, Karina
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 828 - 835
  • [25] Kcentra: A 4-Factor Prothrombin Complex Concentrate for Reversal of Warfarin Anticoagulation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1420): : 53 - 54
  • [26] The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarin
    Varga, Cindy
    Al-Touri, Sultan
    Papadoukakis, Stella
    Caplan, Stephen
    Kahn, Susan
    Blostein, Mark
    TRANSFUSION, 2013, 53 (07) : 1451 - 1458
  • [27] Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients
    Allison, Teresa A.
    Lin, Pei Jen
    Gass, Jennifer A.
    Chong, Kenneth
    Prater, Samuel J.
    Escobar, Miguel A.
    Hartman, Heather D.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (09) : 903 - 908
  • [28] Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department
    Maguire, Michelle
    Fuh, Lanting
    Goldstein, Joshua N.
    Marshall, Ariela L.
    Levine, Michael
    Howell, Melissa L.
    Parry, Blair A.
    Rosovsky, Rachel
    Hayes, Bryan D.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2019, 20 (04) : 619 - 625
  • [29] Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor PCC
    Zahir, Hamim
    Vandell, Alexander
    Desai, Madhuri
    Maa, Jen-Fu
    Dishy, Victor
    Lomelli, Barbara
    Feussner, Annette
    Feng, Wenquin
    He, Ling
    Grosso, Michael A.
    Lanz, Hans J.
    Brown, Karen S.
    CIRCULATION, 2014, 130 (23) : 2116 - 2116
  • [30] COMPARISON OF FIXED-DOSE AND WEIGHT-BASED 4-FACTOR PCC TO REVERSE WARFARIN-ASSOCIATED HEMORRHAGE
    Peters, Nicholas
    Roque, Tara
    Carmody, Brednan
    CRITICAL CARE MEDICINE, 2020, 48
12345